Dauntless Pharmaceuticals Overview
- Year Founded
-
2015

- Status
-
Private
- Employees
-
2

- Latest Deal Type
-
Out of Business
Dauntless Pharmaceuticals General Information
Description
Developer of specialty therapeutics designed to offer a non-injectable somatostatin analog alternative. The company's therapeutics include inhibitors of growth hormone that are administered solely by injecting in approved products and is used as first-line pharmacotherapy for two orphan diseases, acromegaly and neuroendocrine tumors, enabling patients with a non-invasive alternative to benefit from short-acting therapy.
Contact Information
Website
www.dauntlessph.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 9920 Pacific Heights Boulevard
- Suite 150
- San Diego, CA 92121
- United States
+1 (858) 000-0000
Dauntless Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 27-Oct-2021 | 0000 | Completed | Out of Business | ||
2. Early Stage VC (Series A1) | 09-Feb-2018 | 0000 | 0000 | Completed | Clinical Trials - General | |
1. Early Stage VC (Series A) | 21-Jul-2015 | $12M | $12M | Completed | Startup |
Dauntless Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of specialty therapeutics designed to offer a non-injectable somatostatin analog alternative. The company's th
Drug Discovery
San Diego, CA
2
As of 2020
0000
00000000 00
0000
Dauntless Pharmaceuticals Competitors (38)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cerecin | Venture Capital-Backed | Singapore, Singapore | 00 | 00000 | 00000000000 | 00000 |
0000000 | Venture Capital-Backed | Framingham, MA | 00 | 000.00 | 00000000000 | 000.00 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
0000000000 | Formerly VC-backed | Cambridge, MA | 00 | 0000 | 000000&0 | 0000 |
00000 000000000000 | Formerly VC-backed | Waltham, MA | 000 | 00000 | 00000000 | 00000 |
Dauntless Pharmaceuticals Patents
Dauntless Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3713545-A1 | Therapeutic compound formulations | Inactive | 22-Nov-2017 | 0000000000 | |
US-20200281857-A1 | Therapeutic compound formulations | Inactive | 22-Nov-2017 | 0000000000 | |
EP-3713660-A1 | Membrane emulsification device for microsphere creation | Inactive | 22-Nov-2017 | 0000000000 | |
US-20200353419-A1 | Membrane emulsification device for microsphere creation | Inactive | 22-Nov-2017 | 0000000000 | |
EP-3630059-A1 | Peptide compositions and methods of use | Inactive | 26-May-2017 | A61K9/0043 |